Daytime and nighttime glycemic control with control-IQ technology vs. standard therapy in type 1 diabetes: a systematic review and meta-analysis with trial sequential analysis and GRADE assessment

Daytime and nighttime glycemic control with control-IQ technology vs. standard therapy in type 1 diabetes: a systematic review and meta-analysis with trial sequential analysis and GRADE assessment

Abstract Background Automated insulin delivery showed better results than standard insulin therapy, such as MDI. Therefore, we aimed to discuss the efficacy of Control IQ hybrid closed loop (HCL) during the daytime and nighttime for the type 1 diabetic population without restriction in age group or...

Full description

Saved in:
Bibliographic Details
Main Authors: Rahma Mogahed Rateb, Ammar Salah, Ahmed Kertam, Youssef Adel Youssef Ashmawi, Nourhan Hatem Mahmoud, Eslam Afifi, Ahmed Bayoumi, Salma Allam, Mohamed Saad Rakab
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Control IQ
Artificial pancreas
Closed loop
Type 1 diabetes
Online Access:https://doi.org/10.1186/s13098-025-01906-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items